Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2007-10-31
2010-11-16
Belyavskyi, Michail A (Department: 1644)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S388100, C530S388150
Reexamination Certificate
active
07834157
ABSTRACT:
A new family of immunoreceptor molecules of the immunoglobulin superfamily, (LIR) polypeptides is described. Disclosed are sequences encoding LIR family members and their deduced amino acid sequences, polypeptides encoded by DNA that hybridize to oligonucleotide probes having defined sequences, processes for producing polypeptides of the LIR family, and antagonistic antibodies to LIR family members. LIR family members can be used to treat autoimmune diseases and disease states associated with suppressed immune function.
REFERENCES:
patent: 6140076 (2000-10-01), Adema et al.
patent: 6448035 (2002-09-01), Cosman
patent: 6479638 (2002-11-01), Adema et al.
patent: 2003/0105303 (2003-06-01), Adema et al.
patent: WO 98/09638 (1998-03-01), None
patent: WO 98/24906 (1998-06-01), None
patent: WO 98/31806 (1998-07-01), None
Samaridis et al., “Cloning of novel immunoglobulin superfamily receptors expressed on human myeloid and lymphoid cells: structural evidence for new stimulatory and inhibitory pathways”, Eur. J. Immunol., 27:660-665 (1997).
Rojo et al., “Type I transmembrane receptor with inhibitory function in mouse mast cells and NK cells”, J. Immunol., 158(1):9-12 (1997).
Hayami et al., “Molecular cloning of a novel murine cell-surface glycoprotein homologous to killer cell inhibitory receptors”, J. Bio. Chem., 272:7320-7327 (1999).
Kubagawa et al., “A novel pair of immunoglobulin-like receptors expressed by B cells and myeloid cells”, Proc. Nat'l. Acad. Sci. USA, 94:5261-5266 (1997).
Cella et al., “A novel inhibitory receptor (ILT3) expressed on monocyates, macrophages, and dendritic cells involved in antigen processing”, J. Exp. Med., 1185(10)1743-1751 (1997).
Colonna et al., “Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognitiono by human natural killer cells”, Science, 268:405-408 (1995).
Moretta et al., “Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells”, J. Exp. Med., 182:875-884 (1995).
Katz et al., “Mouse mast cell gp49B1 contains two immunoreceptor tyrosine-based inhibition motifs and suppresses mast cell activation when coligated with the high-affinity Fc receptor or IGE”, Proc. Nat'l. Acad. Sci. USA, 93:10809-10814 (1996).
Biassoni et al., “The human leukocyte antigen (GLC)-C specific ‘activatory’ or ‘inhibitory’ natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions”, J. Exp. Med., 183:645-640 (1996).
Burshtyn et al., “Recruitment of tyrosine phosphatase HCP by the killer cell inhibitory receptor”, Immunity, 4:77-85 (1996).
Fry et al., “Phosphotyrosines in the killer cell inhibitory receptor motif of NKB1 are required for negative signaling and for association with protein tyrosine phosphatase 1C”, Exp. Med., 184:295-300 (1996).
Lanier et al., “Natural killer cell receptors and MHC class I interactions”, 9(1):126-131 (1997).
Imboden, “Inate immunity: turning off natural killers”, Current Bio., 6(9):1070-1072 (1996).
Arm et al., “Molecular identification of a novel family of human Ig superfamily members that possess immunoreceptor tyrosine-based inhibition motifs and homology to the mouse gp49B1 inhibitory receptor”, J. Immunol., 159(5):2342-2349 (1997).
Cosman et al., “A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules”, Immunity, 7:273-282 (1997).
Borges et al., “A family of human lymphoid and myeloid Ig-like receptors, some of which bind to MHC class I molecules”, J. Immunol., 159(11):5192-5196 (1997).
Lanier, “Natural killer cell receptors and MHC class I interactions”, 9(1):126-131 (1997).
Hillier et al., GenBank Accession No. 95687 (1996).
Samaridis et al., GenBank Accession No. U82279 (1997).
Naeve et al., “Accuracy of automated DNA sequencing; a multi-laboratory comparison of sequencing results”, Biotechniques, 19(3):448-452 (1995).
Burgess, W. et al., “Possible dissociation of the heparin-binding and mitogenic activities of heparin-binding (acidic fibroblast) growth factor-1 from its receptor-binding activities by site-directed mutagenesis of a single lysine residue,”J. Cell Biol., 111:2129-2138, 1990.
Metzler, W. et al., “Solution structure of human CTLA-4 and delineation of a CD80/CD86 binding site conserved in CD28,”Nat. Struc. Biol., 4(7):527-531, 1997.
Mikayama, T. et al., “Molecular closing and functional expression of a cDNA encoding glycosylation-inhibiting factor,”Proc. Natl Acad Sci. USA, 90:10056-10060, 1993.
Skolnick and Fetrow, “From genes to protein structure and function: novel application sof computational approaches in the genomic era,”Trends in Biotech., 18(1):34-39, 2000.
Belyavskyi Michail A
Immunex Corporation
Perkins Patricia Anne
LandOfFree
Family of immunoregulators designated leukocyte... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Family of immunoregulators designated leukocyte..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Family of immunoregulators designated leukocyte... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4195656